
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine f... Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of hepatitis B. Dynavax operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.56 | -4.02877697842 | 13.9 | 14.07 | 13.34 | 2127335 | 13.77011316 | CS |
4 | -0.16 | -1.18518518519 | 13.5 | 14.63 | 13.34 | 2923634 | 14.00244685 | CS |
12 | 0.47 | 3.6519036519 | 12.87 | 14.63 | 11.81 | 2226924 | 13.40496836 | CS |
26 | 2.54 | 23.5185185185 | 10.8 | 14.63 | 10.12 | 2127406 | 12.70240495 | CS |
52 | 0.75 | 5.95710881652 | 12.59 | 14.63 | 9.74 | 2128359 | 11.995436 | CS |
156 | 2.4 | 21.9378427788 | 10.94 | 17.48 | 7.26 | 1957324 | 12.14046229 | CS |
260 | 9.87 | 284.438040346 | 3.47 | 21.39 | 2.89 | 2760050 | 10.62383386 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions